Share

September 24, 2019; 93 (13) CORRECTIONS

Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine

First published September 24, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007921
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
300

Share

See original article:

Article Information

vol. 93 no. 13 608
DOI: 
https://doi.org/10.1212/WNL.0000000000007921
PubMed: 
31551279
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published September 24, 2019.
Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    View Full Text

    Article usage

    Article usage: September 2019 to February 2023

    AbstractFullPdfSource
    Sep 2019212434Highwire
    Oct 201926140Highwire
    Nov 20190256Highwire
    Dec 20190105Highwire
    Jan 2020092Highwire
    Feb 202004517Highwire
    Mar 2020063Highwire
    Apr 20200126Highwire
    May 20200195Highwire
    Jun 2020082Highwire
    Jul 2020081Highwire
    Aug 20200138Highwire
    Sep 2020120Highwire
    Oct 2020077Highwire
    Nov 20200108Highwire
    Dec 20200143Highwire
    Jan 20210811Highwire
    Feb 20210163Highwire
    Mar 20210104Highwire
    Apr 2021033Highwire
    May 2021364Highwire
    Jun 2021094Highwire
    Jul 2021198Highwire
    Aug 2021154Highwire
    Sep 2021012Highwire
    Oct 20210518Highwire
    Nov 20210822Highwire
    Dec 20210121Highwire
    Jan 2022044Highwire
    Feb 20221223Highwire
    Mar 20220179Highwire
    Apr 2022071Highwire
    May 202201312Highwire
    Jun 2022056Highwire
    Jul 2022163Highwire
    Aug 2022032Highwire
    Sep 2022058Highwire
    Oct 2022055Highwire
    Nov 2022054Highwire
    Dec 2022097Highwire
    Jan 20231103Highwire
    Feb 2023052Highwire

    Letters: Rapid online correspondence

    No comments have been published for this article.
    Comment

    REQUIREMENTS

    If you are uploading a letter concerning an article:
    You must have updated your disclosures within six months: http://submit.neurology.org

    Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

    If you are responding to a comment that was written about an article you originally authored:
    You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
    and apply to letter.

    Submission specifications:

    • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
    • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
    • Submit only on articles published within 6 months of issue date.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Related Articles

    Alert Me

    Recommended articles